ABSTRACT -Background -Celiac disease is an autoimmune enteropathy triggered by the ingestion of gluten in genetically susceptible individuals. Almost all celiac patients carry immune recognition genes coding for HLA-DQ2.5 and DQ8 heterodimers. Over the last few years, great importance has been given to HLA-DQ2.2 as probable predisposing variant, although controversies still exist regarding its relevance. Objective -The aim of our study was to determine the possible existence of an association between HLA-DQ2.2 and celiac disease in Brazilian children by analyzing the prevalence of the predisposing variants for celiac disease in a representative group of children of a population in which this determination is still missing. Methods -HLA-DQ typing was performed in samples from a group of celiac (n=100) and non-celiac children (n=110). All samples were tested for the presence of the following variants: DQA1*05-DQB1*02 (DQ2.5), DQA1*03-DQB1*03:02 (DQ8) and DQA1*02:01-DQB1*02:02 (DQ2.2). Fisher`s exact test was used for statistical analysis. Results -In the group of 100 celiac children, 78 (78%) were positive for DQ2, 13 (13 %) were DQ2/DQ8 and 6 (6%) were DQ8 positives. The HLA-DQ pattern in the 110 non-celiac children was as follows: positive for DQ2 in 33 (29.9%) samples, in 2 (1.8 %) was positive for DQ2/DQ8 and in 15 (13.6%) was positive for DQ8. We found significant differences between the distribution of some but not all of the analyzed alleles when comparing celiac and non-celiac children. Conclusion -The genotyping of celiac disease HLA-DQ predisposing alleles showed similarities with HLA-DQ patterns found in both European and non-European populations, which may be a reflection of the miscegenation, which gave origin to the current Brazilian population. No significant association was found between DQ2.2 variant and celiac disease in the studied population.
INTRODUCTION
Celiac disease (CD) is a common autoimmune enteropathy (prevalence estimated at 1% in Caucasian population) (1) triggered by the ingestion of gluten in genetically susceptible individuals. Gluten is a protein component in wheat (a staple food for most populations in the world) and other cereals like rye and barley (2) . During the pathogenesis of celiac disease, a T-cell mediated response to dietary gluten causes the overproduction of inflammatory cytokines, which contribute to the damage of the intestinal mucosa. A B-cell mediated response is also activated, with an increased production of IgA anti-tissue transglutaminase antibodies (IgAtTG) (3) . Anti-IgA-tTG antibodies, together with anti-endomysium antibodies (IgA-EMA) can be detected in patients' sera, and are the first step in the diagnosis of CD (4) . An outstanding feature of CD is that almost all affected individuals carry immune recognition genes coding for HLA-DQ2. 5 and/or DQ8 heterodimers, which facilitate CD4 + T-cell recognition of specific gluten-derived peptides (3) . These heterodimers are encoded by two sets of HLA alleles: DQA1*05 -DQB1*02 (DQ2.5), DQA1*03 -DQB1*03:02 (DQ8) (3) . Therefore, during a CD diagnostic workup, the absence of these specific DQA1 and DQB1 alleles has a near perfect negative predictive value (5) . However, there are still some patients that don´t carry neither of these predisposing variants. In an attempt to describe the genetic bases of the disease on those patients, some authors found significance in the association between celiac disease and HLA-DQ2.2 (DQA1*02:01 -DQB1*02:02) (6) but they are still a lot of controversies regarding the role of this heterodimer.
Many studies reflect the importance of genetic factors in the pathogenesis of CD (7) . A recent work from Anderson et al. (2013) suggested that a combination of human leukocyte antigen (HLA) typing and confirmatory serology could decrease the number of unnecessary endoscopies as well as the number of false negatives and/or positive diagnoses. For this to be useful, we should know the prevalence of these genotypes in the area of interest as they proved to be slightly different between populations around the world (7) (8) (9) . The aim of our work was to study the association between HLA-DQ2.2 and celiac disease in Brazilian children by analyzing the prevalence of the predisposing variants for celiac disease in a population that still lacks this information. 
METHODS

Study population and data collection
This research complied with the principles of the latest Declaration of Helsinki (10) and was approved by the Ethics Committee of the University of Brasilia, School of Health Sciences, protocol CEP-FS 132/08. After extensive explanation on purpose and procedures involved in the research a written informed consent was obtained from the children's parents or caregivers.
The study population consisted in a group of celiac and nonceliac children from the city of Brasilia, Brazil. Brasilia, from the viewpoint of population studies, has the advantage of being considered representative of the Brazilian population at large given its past-history of high rate of migratory waves from a variety of Brazilian regions.
Whole blood (approximately 5 mL) was collected by venipuncture from children attending the outpatient clinic of the Celiac Disease Research Center of the University Hospital of Brasilia. The groups were composed by 100 celiac children (41 male, 59 female; mean age: 6.9 yrs, median 8 yrs, age range: 1 to 15 yrs), and 110 presumably healthy non-celiac children (47 males, 63 females; mean age: 7 yrs, median 8 yrs, age range: 1 to 15 yrs). Non-celiac children underwent IgA-tTG and IgA-EMA assays to exclude CD, all yielding negative results. Celiac children had already been diagnosed following the European Society of Pediatric Gastroenterology, Hepatology and Nutrition (ESPGHAN) criteria (4) .
HLA genotyping
DNA extraction was performed in all samples using Illustra 
Statistical analysis
Frequencies of both groups were compared by using Fisher`s exact test. Results were considered significant when P<0.05. Statistical analysis was performed using GraphPad Prism Version 5.
RESULTS
From a total of 100 celiac children, 51 (51%) tested positive for DQ2.5 only; 22 (22%) for DQ2.5/DQ2.2; 5 (5%) for DQ2.2 only; 7 (7%) for DQ2.5/DQ8; 6 (6%) for DQ2.2/DQ8; 6 (6%) for DQ8 only; 1 (1%) was DQB1*02 positive; 1 (1%) showed low risk predispo sing alleles and 1 (1%) tested negative for all of the searched alleles.
All 110 non-celiac children tested negative for the performed serologic tests. Genetic analysis showed that 16 (14.5%) were DQ2.5 only, 4 (3.6%) were DQ2.5/DQ2.2, 13 (11.8%) were DQ2.2 only, 1 (0.9%) DQ2.5/DQ8, 1 (0.9%) DQ2.2/DQ8, 15 (13.6%) DQ8 only, 2 (1.8%) were DQB1*02 positives, 29 (26.4%) showed low risk predisposing alleles and 29 (26.4%) tested negative for all of the searched alleles. 
DISCUSSION
Over the last years, great importance has been given to HLA genotyping in the prediction and prognosis of many autoimmune diseases including celiac disease. However, due to their heterogeneous distribution in different populations around the world, genotypes' prevalence must be first characterized for the local population to be able to compare it to at-risk subjects. The inclusion of HLA-DQ2.2 as a predisposing variant for celiac disease remains under discussion with it being significant for some but not all studied populations (6) (7) (8) (9) (10) (11) (12) (13) . Although about 30%-40% of the general population carry HLA-DQ2 and/or DQ8 without developing CD, these alleles are absent in less than 0.5% of CD patients (14) . HLA typing is considered an excellent tool to be used before performing more invasive tests like endoscopy, when serology is ambiguous in subjects being investigated for CD (4) (5) (6) (7) (8) . Additionally, in individuals considered at high risk for CD as first-degree relatives, patients with immunoglobulin A deficiency, other autoimmune diseases or with Down, Turner or Williams syndromes, the HLA typing is used to exclude those in which these alleles are absent from further investigation. The absence of predisposing alleles spares individuals of unnecessary serial serological testing while confirmation of their presence reflects an increased likelihood of developing CD. Thereby, in individuals disclosing HLA predisposing alleles on genetic testing periodic screening for autoantibodies against IgA tTG and IgA EMA should be considered to avoid non-detection of subclinical or silent forms of the disease (5) . As already stated above, the prevalence of CD predisposing DQ alleles was already described in many countries around the word and it showed some differences between them (3) . In this work, we evaluated the presence of these alleles in both celiac and non-celiac children from a population that still lacked this information, the Brazilian population. As expected, we found many significant differences in the distribution of the analyzed alleles which supports the existence of strong genetic basis in CD (3, 4) (TABLE 1) . However, no significant differences were found between groups when analyzing HLA-DQ8 genotype. While it might be attributed to the sample size, an increased prevalence of this variant was already reported in the general population of another South-American country, Chile, which showed strong Amerindian ancestry (15) . In addition, we included in our work HLA-DQ2.2 as a predisposing variant whereby several celiac individuals that initially tested positive for DQ8 only (n=12) were actually DQ2.2/DQ8 (n=6). The total prevalence of predisposing variants in celiac and non-celiac individuals found in our study was similar to the ones showed in other studies from Italy and Libya (16, 17) . (TABLE 2 ). The extremely high percentage of patients with CD carrying either HLA-DQ2.5 or HLA-DQ8 has led to the common practice of excluding CD in patients without these HLA types (4) .
However, other reports describe patients with CD who lack both HLA-DQ2.5 and -DQ8, making the validity of this strong negative predictive value questionable (13) (14) (15) (16) (17) (18) . Previous studies already showed that a great proportion of DQ2.5 and DQ8 negative CD patients were positives for the DQ2.2 variant (6) (7) (8) (9) (10) (11) (12) (13) (14) (15) (16) (17) (18) concluding that DQ2.2 should be considered as a risk variant for celiac disease. Other studies also gave details on the probable molecular role of the heterodimer coded by this variants (18, 19) . However, we found no significant difference between celiac and non-celiac children, suggesting that this variant is not relevant for the population under analysis.
Although our study had some limitations regarding the sample size; presently, further studies are underway in our laboratory to overcome these drawbacks, including a broader population both in sample size and patient's age range.
CONCLUSION
The genotyping of celiac disease HLA-DQ predisposing alleles showed similarities with both European and non-European patterns, which may be a reflection of the miscegenation that originated the actual Brazilian population. No significant association was found between DQ2.2 variant and celiac disease in the studied population. 
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